MX2009011817A - Formulaciones de aminoacido n-halogenado que contienen acido alifatico. - Google Patents

Formulaciones de aminoacido n-halogenado que contienen acido alifatico.

Info

Publication number
MX2009011817A
MX2009011817A MX2009011817A MX2009011817A MX2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A
Authority
MX
Mexico
Prior art keywords
amino acid
halogenated amino
formulations
acid
aliphatic acid
Prior art date
Application number
MX2009011817A
Other languages
English (en)
Inventor
Masood A Chowhan
Wesley Wehsin Han
L Wayne Schneider
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of MX2009011817A publication Critical patent/MX2009011817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eyeglasses (AREA)

Abstract

La presente invención se refiere a métodos para el tratamiento de un tejido infectado que comprende tratar el tejido infectado con una formulación que comprende un aminoácido N-halogenado y un ácido alifático; esta especificación también describe métodos para mejorar la actividad antimicrobiana de una formulación que comprende un aminoácido N-halogenado, el método comprendiendo agregar un ácido alifático a dicha formulación.
MX2009011817A 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado que contienen acido alifatico. MX2009011817A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91527107P 2007-05-01 2007-05-01
PCT/US2008/061950 WO2008134692A1 (en) 2007-05-01 2008-04-30 Aliphatic acid-containing n-halogenated amino acid formulations

Publications (1)

Publication Number Publication Date
MX2009011817A true MX2009011817A (es) 2009-11-13

Family

ID=39616420

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011817A MX2009011817A (es) 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado que contienen acido alifatico.

Country Status (17)

Country Link
US (2) US20080275126A1 (es)
EP (1) EP2139520B1 (es)
JP (2) JP2010526084A (es)
KR (1) KR20100017156A (es)
CN (1) CN101678105A (es)
AR (1) AR066371A1 (es)
AU (1) AU2008245460B2 (es)
BR (1) BRPI0811073A2 (es)
CA (1) CA2684101A1 (es)
CL (1) CL2008001283A1 (es)
ES (1) ES2432408T3 (es)
MX (1) MX2009011817A (es)
RU (1) RU2009144291A (es)
TW (1) TW200902092A (es)
UY (1) UY31057A1 (es)
WO (1) WO2008134692A1 (es)
ZA (1) ZA200907052B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2608047T3 (es) * 2008-04-10 2017-04-05 Waldemar Gottardi Composiciones que comprenden amina N-halogenada o N,N-dihalogenada para el tratamiento y profilaxis de infecciones broncopulmonares
WO2009127924A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027965B2 (ja) * 1980-02-23 1985-07-02 東洋コンタクトレンズ株式会社 コンタクトレンズに付着した汚れの除去方法
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
WO1996003158A1 (en) * 1994-07-22 1996-02-08 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6387427B1 (en) * 2000-09-28 2002-05-14 Nestec S.A. Method of preservation of a food product
JP4502641B2 (ja) * 2002-01-24 2010-07-14 ティルタン ファーマ リミテッド 抗癌組み合わせおよびその使用方法
CA2535926C (en) 2003-08-18 2012-10-09 Novacal Pharmaceuticals, Inc. N,n-dihalogenated amino acids and derivatives
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
WO2007044559A1 (en) * 2005-10-06 2007-04-19 Novabay Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids

Also Published As

Publication number Publication date
US20080275126A1 (en) 2008-11-06
AU2008245460A1 (en) 2008-11-06
UY31057A1 (es) 2008-10-31
BRPI0811073A2 (pt) 2014-12-09
ES2432408T3 (es) 2013-12-03
RU2009144291A (ru) 2011-06-10
CL2008001283A1 (es) 2009-01-16
KR20100017156A (ko) 2010-02-16
WO2008134692A1 (en) 2008-11-06
ZA200907052B (en) 2010-12-29
JP2010526084A (ja) 2010-07-29
EP2139520A1 (en) 2010-01-06
AR066371A1 (es) 2009-08-12
JP2014098037A (ja) 2014-05-29
CA2684101A1 (en) 2008-11-06
CN101678105A (zh) 2010-03-24
AU2008245460B2 (en) 2013-08-22
EP2139520B1 (en) 2013-08-21
TW200902092A (en) 2009-01-16
US20110060044A1 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
EP2340821A4 (en) PROPHYLAXIS AGENTS / ADULTS OF ADULT DISEASES WITH 5-AMINOLEVULINIC ACID, A 5-AMINOLEVULIC ACID DERIVATIVE OR 5-AMINOLEVULIC ACID SALT OR 5-AMINOLEVULIC ACID DERIVATIVE AS AN ACTIVE SUBSTANCE
CY1117547T1 (el) Ενωση πυραζολοκινολινης
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
EP2349279A4 (en) ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF
MY164274A (en) Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
CR20200220A (es) FORMAS SÓLIDAS DE ÁCIDO {[5-(3-CLOROFENIL)-3-HIDROXIPIRIDIN-2-CARBONIL]AMINO}ACÉTICO, COMPOSICIONES, Y USOS DE LAS MISMAS (Divisional 2016-0222)
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
MX2012010161A (es) Metodo para tratar el mal de parkinson.
WO2010111640A3 (en) Anti-influenza formulations and methods
NZ597510A (en) NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
MX2012003324A (es) Compuesto de glicina.
MX343931B (es) Tratamiento de la esclerosis lateral amiotrofica con el uso de celulas derivadas del cordon umbilical.
WO2011126250A3 (ko) Pde5 억제제를 함유하는 피부 주름 개선용 조성물
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
MX2011009482A (es) Metodo o sistema que usa biomarcadores para el monitoreo de un tratamiento.
MX2009011819A (es) Formulaciones de aminoacido n-halogenado.
EA201171431A1 (ru) Применение комбинации d-аспарагиновой и l-аспарагиновой кислот или их солей для лечения мужского бесплодия
MX2009011818A (es) Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.
MX2009011817A (es) Formulaciones de aminoacido n-halogenado que contienen acido alifatico.
WO2011026577A3 (de) Zubereitungen mit wasserunlöslichen polymeren aminen zur verminderung von körpergeruch
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.
WO2014006571A3 (en) Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof
ECSP12012332A (es) Asociación de inhibidores de la xantina oxidasa y la instatina y su uso
WO2011018739A3 (en) Use of a composition for treatment and/or prophylaxis of plants and relative composition

Legal Events

Date Code Title Description
FA Abandonment or withdrawal